SK bioscience Co., a biopharmaceutical arm of South Korea's SK Group, said Thursday it will accelerate the development of a ...

With $30 million in funding from the Coalition for Epidemic Preparedness Innovations (CEPI), Merck & Co. | The project, which involves Merck, SK Biosciences, Hilleman Laboratories and CDMO IDT ...

Lab-grown antibodies which can be given to patients to reinforce their immune response ...

An Ebola doctor-turned-patient had virus in his eyeball months after recovery. — -- For one Ebola doctor-turned-patient, being discharged with virus-free blood wasn't the end of his brush with ...

GOMA, Congo (AP) — Congo's authorities announced earlier this week a new Ebola outbreak, which has killed more than a dozen people in a southern province. Samples analyzed at the National Institute ...

He was exposed to the virus while working at a west Africa hospital. — -- A Tennessee doctor who placed himself in quarantine after volunteering in West Africa, where the Ebola virus is rampant, ...

At the end of last year, an Ebola disease outbreak in the Democratic Republic of Congo’s Kasai province was officially declared over.

Ebola virus executes its replication cycle through a tightly orchestrated sequence of events, but the host factors that govern the timing of these steps have remained poorly defined. In this talk, I ...

"It's a great example ... for a new vaccine that has enough preclinical safety and manufacturing quality control to be brought into the field at such an early stage," former ASTMH president Thomas ...

The US Food and Drug Administration (FDA) has approved the first vaccine for the prevention of Ebola caused by the deadly Zaire strain of the virus, which killed more than 11,000 people during the ...